Patent Assignment
Reel/Frame 012833/0271
Assignment of Assignor's Interest
Recorded: 2002-04-09
Pages: 2
Assignor
INEX PHARMACEUTICALS CORPORATION
Executed: 2002-04-04
Assignee
PROTIVA BIOTHERAPEUTICS, INC.
150-8900 GLENLYON PARKWAY, GLENLYON BUSINESS PARK, BARNABY B.C.,, V5J 5, CANADA
Covered Property
(1)
Sensitizing Cells to Compounds Using Lipid-Mediated Gene and Compound Delivery
Patent:
6,410,328 →
Application:
09/243,104 →
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement
Dec 29, 2011
From: PROTIVA BIOTHERAPEUTICS, INC.
To: SILICON VALLEY BANK
Reel/Frame 027463/0613 →
Merger
Feb 20, 2018
From: PROTIVA BIOTHERAPEUTICS INC.
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 045384/0278 →
Release of Security Interest
Feb 16, 2023
From: SILICON VALLEY BANK
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 062721/0199 →